On September 24, 2022, John Bolger notified the Board of Directors of Fulgent Genetics, Inc. (the Company) of his decision to resign from the Board. Mr. Bolger resigned as the Chair of the Audit Committee and member of the Compensation Committee and Nominating and Corporate Governance Committee, effective as of September 24, 2022.